Article Details

Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates

Retrieved on: 2021-08-05 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates. View article details on hiswai:

Excerpt

Strongbridge Biopharma (SBBP) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.10.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up